aprepitant oral / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aprepitant oral / Generic mfg.
NCT03683225: A Study to Evaluate in Patients With Parkinsonian Type Disorders

Active, not recruiting
2
24
US
CTC-413
Chase Therapeutics Corporation
Idiopathic Parkinson Disease
12/24
12/24

Download Options